TY  - GEN
AU  - Reusch,J
AU  - Stewart,M W
AU  - Perkins,C M
AU  - Cirkel,D T
AU  - Ye,J
AU  - Perry,C R
AU  - Reinhardt,R R
AU  - Bode,B W
TI  - Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
SN  - 1463-1326
PY  - 2015///0825
KW  - Blood Glucose
KW  - drug effects
KW  - Diabetes Mellitus, Type 2
KW  - drug therapy
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glucagon-Like Peptide 1
KW  - administration & dosage
KW  - Humans
KW  - Hypoglycemia
KW  - chemically induced
KW  - Hypoglycemic Agents
KW  - Incretins
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Pioglitazone
KW  - Thiazolidinediones
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12382
ER  -